4.5 Article

Targetome Profiling, Pathway Analysis and Genetic Association Study Implicate miR-202 in Lymphomagenesis

Journal

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume 22, Issue 3, Pages 327-336

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-12-1131-T

Keywords

-

Funding

  1. NIH [CA154653, CA122676]

Ask authors/readers for more resources

Background: miRNAs have been implicated in numerous tumorigenic pathways, and previous studies have associated miR-202 dysregulation with various cancer types, including follicular lymphoma. Methods: The miR-202 targetome was identified by ribonucleoprotein immunoprecipitation-microarray (RIP-Chip), and functional interactions among identified targets were investigated using the Ingenuity Pathway Analysis tool. We also conducted a population-based genetic association study of a polymorphism within the miR-202 stem-loop sequence and risk of non-Hodgkin lymphoma. In vitro gain-of-function experiments were further conducted to elucidate the functional significance of the variant. Results: A total of 141 potential members of the miR-202 targetome were identified by a transcriptome-wide RIP-Chip assay. Functional interactions among identified targets suggested that miR-202-regulated genes are involved in biologic pathways relevant for hematologic function and cancer. Consistent with this, a genetic association analysis using human blood samples revealed a significant association between a germline mutation (rs12355840) in the miR-202 precursor sequence and follicular lymphoma risk. An in vitro functional assay further showed that the variant allele resulted in diminished miR-202 levels, possibly by altering precursor-processing efficiency. Conclusions: Taken together, our findings suggest that miR-202 is involved in follicular lymphomagenesis. Impact: These findings implicate miR-202 as a potential tumor suppressor in follicular lymphoma and warrant the investigation of miR-202 as a novel biomarker of follicular lymphoma risk. Cancer Epidemiol Biomarkers Prev; 22(3); 327-36. (C)2013 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia

Jonathan D. Lee, Joao A. Paulo, Ryan R. Posey, Vera Mugoni, Nikki R. Kong, Giulia Cheloni, Yu-Ru Lee, Frank J. Slack, Daniel G. Tenen, John G. Clohessy, Steven P. Gygi, Pier Paolo Pandolfi

Summary: The iDAPT method allows for detection and inference of transcription factor gene regulatory networks, protein interactors, and chromatin accessibility regulation. It serves as a platform for studying dynamic epigenomic landscapes and the transcription factor components associated with biological phenomena and disease.

NATURE METHODS (2021)

Review Oncology

The Role of LncRNAs in Uveal Melanoma

Paula Milan-Rois, Anan Quan, Frank J. Slack, Alvaro Somoza

Summary: Uveal melanoma is a rare and deadly cancer that requires novel treatment and diagnostic approaches. Long non-coding RNAs (lncRNAs) are crucial in cancer and other diseases, offering potential as therapeutic targets and diagnostic markers. Understanding lncRNAs related to uveal melanoma could inspire the development of new treatments and diagnostics, with their interaction with other non-coding RNAs playing a significant role in cancer development.

CANCERS (2021)

Review Oncology

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma

Vida Karimnia, Frank J. Slack, Jonathan P. Celli

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with current clinical trials showing limited improvements in patient survival. Photodynamic therapy (PDT) has emerged as a potential approach for treating pancreatic tumors based on studies indicating its effectiveness in activating photosensitizing agents in target tissues.

CANCERS (2021)

Article Multidisciplinary Sciences

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

Jeffrey R. Haswell, Kaia Mattioli, Chiara Gerhardinger, Philipp G. Maass, Daniel J. Foster, Paola Peinado, Xiaofeng Wang, Pedro P. Medina, John L. Rinn, Frank J. Slack

Summary: This study describes a method to modulate lncRNA expression during human embryonic stem cell differentiation and identifies key lncRNA loci involved in differentiation. A clustering approach was developed to infer mechanisms of action of lncRNA hits, leading to the validation of FOXD3-AS1 as a functional lncRNA essential for pluripotency and differentiation. The cell lines and methodology presented in this study can be adapted to discover and characterize novel regulators of differentiation into any lineage.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2

Soo Mi Lee, Kenneth M. Kaye, Frank J. Slack

Summary: The study identified miR-127-3p as a potential tumor suppressor in Kaposi's sarcoma, inhibiting KSHV-driven cellular transformation and proliferation by directly targeting the oncogene SKP2. This led to G(1) cell cycle arrest, activation of the RB protein tumor suppressor pathway, and down-regulation of key oncoprotein transcription factors crucial for KSHV tumorigenesis. Restoring miR-127-3p may serve as a viable therapeutic strategy for Kaposi's sarcoma.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

Transcriptome Profiling of ADAR1 Targets in Triple-Negative Breast Cancer Cells Reveals Mechanisms for Regulating Growth and Invasion

Allison R. Baker, Christos Miliotis, Julia Ramirez-Moya, Talia Marc, Ioannis S. Vlachos, Pilar Santisteban, Frank J. Slack

Summary: ADAR1 plays a critical role in triple-negative breast cancer, and its loss leads to reduced cell growth, invasion, and mammosphere formation. ADAR1 regulates both coding and noncoding targets by altering gene expression level, A-to-I editing, and splicing. The study also reveals that several tumor suppressor miRNAs are upregulated upon ADAR1 loss, suppressing cell-cycle progression and invasion.

MOLECULAR CANCER RESEARCH (2022)

Article Biotechnology & Applied Microbiology

MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state

Wen Cai Zhang, Nicholas Skiados, Fareesa Aftab, Cerena Moreno, Luis Silva, Paul Joshua Anthony Corbilla, John M. Asara, Aaron N. Hata, Frank J. Slack

Summary: In EGFR-mutant lung cancer, drug-tolerant persister cells (DTPCs) show prolonged survival when receiving EGFR tyrosine kinase inhibitor (TKI) treatments. They are a likely source of drug resistance. This study found that upregulation of miR-21-5p and miR-21-3p tune purine metabolism leading to increased drug tolerance.

CANCER GENE THERAPY (2022)

Correction Biotechnology & Applied Microbiology

MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state (Jul, 10.1038/s41417-022-00504-y, 2022)

Wen Cai Zhang, Nicholas Skiados, Fareesa Aftab, Cerena Moreno, Luis Silva, Paul Joshua Anthony Corbilla, John M. Asara, Aaron N. Hata, Frank J. Slack

CANCER GENE THERAPY (2022)

Editorial Material Biochemistry & Molecular Biology

Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics

Sai Pallavi Pradeep, Shipra Malik, Frank J. Slack, Raman Bahal

Summary: RNA therapeutics have become the next-generation therapy for many diseases, using Watson-Crick base-pairing rules to recognize and modulate target RNA. Antisense oligonucleotides (ASOs) are a powerful approach to treat genetic disorders by altering gene expression. PNAs, with their synthetic DNA mimic structure, have been explored as an effective and safe RNA-targeting platform, demonstrating advances in coding and noncoding RNA targeting for therapeutic applications.
Article Biochemistry & Molecular Biology

Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3

Adrienne Vancura, Alejandro H. Gutierrez, Thorben Hennig, Carlos Pulido-Quetglas, Frank J. Slack, Rory Johnson, Simon Haefliger

Summary: This study has found a bias in the evaluation of evolutionary conservation for cancer-related lncRNAs, raising doubts about its relevance in cancer research.

NON-CODING RNA (2022)

Article Cell Biology

The conserved microRNA-229 family controls low-insulin signaling and dietary restriction induced longevity through interactions with SKN-1/NRF2

Latika Matai, Thalyana Stathis, Jonathan D. Lee, Christine Parsons, Tanvi Saxena, Kovi Shlomchik, Frank J. Slack

Summary: Several microRNAs, such as miR-228 and miR-229-66, have been identified as regulators of aging pathways in C. elegans. These microRNAs interact with transcription factors and are required for normal lifespan and longevity. miR-229-66 is specifically involved in lifespan extension through dietary restriction, reduced insulin signaling, and SKN-1 activation.

AGING CELL (2023)

Article Oncology

The Emerging Value of Circular Noncoding RNA Research in Cancer Diagnosis and Treatment

Urmila Jagtap, Erik S. Anderson, Frank J. Slack

Summary: Circular RNAs (circRNA) have gained significant attention as new components of disease mechanisms and potential biomarkers in various diseases, including cancer. They are highly conserved and show specific expression patterns in different developmental stages and diseases. Numerous studies have identified circRNA expression patterns associated with specific cancer types and patient prognosis. This article provides an overview of registered clinical trials investigating the value of circRNAs as cancer biomarkers and discusses their potential in clinical cancer care. Overall, circRNAs are actively being studied as diagnostic, predictive, and prognostic biomarkers, and their potential as therapeutic targets support ongoing translational and clinical research.

CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Small regulatory RNAs: from bench to bedside - a keystone symposia meeting report

Soo Mi Lee, Michael T. Winters, Ivan Martinez, Frank J. Slack

Summary: The Keystone Symposium 'Small Regulatory RNAs: From Bench to Bedside' focused on the biology and therapeutic applications of small regulatory RNAs. The conference aimed to facilitate the translation of research findings into clinical tools and foster collaboration between academia and industry. It provided a platform for scientists to present and discuss their research in the field of small regulatory RNAs.

RNA BIOLOGY (2023)

Review Biochemistry & Molecular Biology

MicroRNAs in Age-Related Proteostasis and Stress Responses

Latika Matai, Frank J. Slack

Summary: Aging is associated with protein misfolding diseases and the failure to maintain proteostasis, due to the accumulation of damaged and misfolded proteins and weakened cellular stress response pathways. MiRNAs play important roles in controlling aging and regulating proteostasis and stress responses during aging and age-related diseases. This review focuses on the role of individual miRNAs in age-associated protein folding and degradation, as well as their relationships with organelle-specific stress response pathways.

NON-CODING RNA (2023)

Article Cell Biology

Severe COVID-19 is associated with molecular signatures of aging in the human brain

Maria Mavrikaki, Jonathan D. Lee, Isaac H. Solomon, Frank J. Slack

Summary: COVID-19 infection is associated with brain aging and emphasizes the value of neurological follow-up in recovered individuals.

NATURE AGING (2022)

No Data Available